Delivery Order SPE2DB22D1017-SPE2DB25FF8XK

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,672.50 firm-fixed-price delivery order is for the supply of 4567377563 ! ARMODAFINIL 250 MG TABLET 30S, with an ultimate completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,793.26 firm fixed-price contract is for the delivery of 4567733105 ARMODAFINIL 250 MG TABLET 30S and has an ultimate completion date of March 31, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,472.03, is for the delivery of armodafinil 250 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,345.00 firm fixed-price delivery order is for the supply of ARMODAFINIL 250 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,958.72 fixed-price delivery order is for the supply of 4,567,731,281 units of the drug Armodafinil 250 mg tablet, with a completion date of March 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,672.50, is a Delivery Order for the procurement of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Armodafinil 250 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $1,742.12 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,672.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Armodafinil 250 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEBAH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,266.66 firm fixed-price delivery order is for the supply of 4567925485 ARMODAFINIL 250 MG TABLET 30S, with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250MG 30S, a prescription medication, with a ceiling value of $1,672.50 and a period of performance through June 12, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF8XK
    Delivery Order

This federal contract award, valued at $3,595.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4567750958 - ARMODAFINIL 250 MG TABLET 30S, and has a completion date of April 1, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation mentioned in the information provided.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/30/25, 10:52 AM